spacer
home > ict > autumn 2017 > keeping track
PUBLICATIONS
International Clinical Trials

Keeping Track

As the global pharmaceutical industry implements serialisation to meet governmental regulatory requirements, other opportunities exist for companies to realise business benefits. The main driver for serialisation is to provide greater integrity to the supply chain, but other meaningful advantages can also be obtained.

Combatting Counterfeits

In addition to tightening up the supply chain and channels of trade, serialisation can provide great efficiencies for processing shipments and knowing what specific packages are included in shipments down to the lowest saleable unit. Tracking information can be updated continuously and provided to brand owners and supply chain partners on dashboards or on mobile applications.

These developments in enhanced track and trace can be employed to more quickly and accurately detect diversion of product to unauthorised regions. To combat counterfeiting, new authentication technologies now exist for linking serial numbers to security features that are unique to each package to detect possible replication of serial numbers by counterfeiters.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Steve Wood is the President and Chief Executive Officer (CEO) of Covectra and holds a Bachelor of Science degree from the US Naval Academy and an MBA from Yale, US. He has over 25 years of experience in processing and packaging machinery, pharma security technologies and integrated systems. Steve is the co-founder/CEO of five different companies and is currently serving as Director of PharmoRx Therapeutics and MedSentry.
spacer
Steve Wood
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for pharmaceutical and medical device applications

Novo Nordisk Pharmatech A/S has entered into an agreement with Signet Chemical Corporation Pvt. Ltd. for the distribution of their pharmaceutical range of quaternary ammonium compounds (FEF® Quats) to the healthcare industry in India, Bangladesh and Sri Lanka.
More info >>

White Papers

What is process characterization?

EXPUTEC

Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drug’s manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >>

 
Industry Events

Drug Discovery 2018

9-10 October 2018, ExCeL Arena, London, UK

ELRIG’s flagship conference, Drug Discovery, has become the largest meeting of life sciences industry professionals in the UK. Now in its 12th year, Drug Discovery 2018 will take place in London’s Excel Arena. This 2-day event will bring together more than 1200 delegates and over 100 exhibiting companies from around the world who will highlight the latest ground-breaking research, discuss cutting-edge advances in the application of laboratory technology to understand disease biology and to identify novel chemical and biological candidate drugs.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement